Pharvaris
PHVS
51 hedge funds and large institutions have $834M invested in Pharvaris in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 3 closing their positions.
500% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 3
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
42% more funds holding
Funds holding: 36 → 51 (+15)
3.49% more ownership
Funds ownership: 79.91% → 83.4% (+3.5%)
3% more capital invested
Capital invested by funds: $809M → $834M (+$25.7M)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$11.6M |
| 2 |
OCA
Octagon Capital Advisors
New York
|
+$11.3M |
| 3 |
PSC
Patient Square Capital
Menlo Park,
California
|
+$4.43M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.63M |
| 5 |
BlackRock
New York
|
+$3.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.75M |
| 2 |
Walleye Capital
New York
|
-$917K |
| 3 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$906K |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$299K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$272K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Bank of America
Charlotte,
North Carolina
| $278 | -$112K | -6,106 | -100% |
|
|
52
Walleye Capital
New York
| – | -$917K | -48,768 | Closed |
|
|
YIH
53
Y-Intercept (HK)
Hong Kong
| – | -$299K | -15,883 | Closed |
|
|
54
Citadel Advisors
Miami,
Florida
| – | -$272K | -14,472 | Closed |
|
PHVS Hedge Fund Activity: Q3 2024 in Review
51 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q3 2024, worth a combined $834M — up 3.2% from $809M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new PHVS positions and 3 closed out — a net gain of 15 holders — while 14 added to existing stakes and 6 trimmed.
The largest buyer was Deerfield Management, adding an estimated $11.6M. The largest seller was T. Rowe Price Associates, cutting an estimated $4.75M.
- 51 institutional investors held Pharvaris (PHVS) as of Q3 2024, up from 36 in Q2 2024.
- Funds reported $834M of Pharvaris stock for Q3 2024, up 3.2% quarter-over-quarter.
- 18 funds opened new Pharvaris positions in Q3 2024 and 3 closed out, a net change of +15 holders.
- The largest Pharvaris buyer in Q3 2024 was Deerfield Management, an estimated $11.6M added.
- The largest Pharvaris seller in Q3 2024 was T. Rowe Price Associates, an estimated $4.75M sold.
Based on aggregated 13F filings for Q3 2024.